New insight into HIV vaccine development
Main Category: HIV / AIDSArticle Date: 17 Feb 2004 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
MADISON (USA)-Mutations that allow AIDS viruses to escape detection by the immune system may also hinder the viruses' ability to grow after transmission to new hosts, scientists at the University of Wisconsin-Madison announced this week in the journal Nature Medicine.
The discovery may help researchers design vaccines that exploit the notorious mutability of HIV by training the immune system to attack the virus where it's most vulnerable.
The work appears alongside a study of HIV-infected people performed by scientists at Harvard Medical School and Oxford University.
The Wisconsin study's lead author, Thomas Friedrich, is a doctoral student working under the direction of David Watkins, professor of pathology at UW-Madison and senior scientist at the Wisconsin National Primate Research Center.
Watkins' team produced an 'escaped' AIDS virus that mimicked events that occur in HIV infection when the virus mutates to become unrecognizable to killer cells known as cytotoxic T-lymphocytes, or CTL.
The researchers found that the mutant virus did not grow as well as the original strain. The mutations, while allowing the virus to escape immune recognition, had also weakened the virus. To model the transmission of escaped viruses between people, the team inoculated monkeys with the mutant virus strain.
They discovered that most of the escape mutations were lost as the virus grew in the monkeys, often restoring original sequences that killer cells could recognize.
Some scientists have theorized that HIV could adapt to the human immune system as the AIDS epidemic develops, becoming less and less recognizable. Watkins said that his group's findings should help allay these fears.
The UW-Madison group has been studying immunity to AIDS viruses since the early 1990s.
Most recently, the researchers have been studying the ways in which viruses mutate to 'escape' recognition by the body's killer cells. Killer cells are white blood cells that perform immune 'surveillance' throughout the body, detecting infected cells and eliminating them before the virus can spread.
'Over 40 million people are now infected with HIV worldwide, and a vaccine is urgently needed,' Watkins said. 'We hope that our findings can be used to help design vaccines that show killer cells how to fight the virus most effectively.'
Jordana Lenon 608-263-7024, jlenon@primate.wisc.edu
NOTE TO PHOTO EDITORS: High-resolution images of Watkins and his lab are available at http://www.news.wisc.edu/newsphotos/watkins.html
Contact: David Watkins
608-265-3380
University of Wisconsin-Madison
Visit our hiv / aids section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/5957.php>
APA
http://www.medicalnewstoday.com/releases/5957.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



